Table: begin end state 1 11 cytoplasmic 12 32 transmembrane 33 37 non-cytoplasmic 38 56 transmembrane 57 77 cytoplasmic 78 103 transmembrane 104 116 non-cytoplasmic 117 136 transmembrane 137 145 cytoplasmic 146 169 transmembrane 170 189 non-cytoplasmic 190 213 transmembrane 214 232 cytoplasmic 233 254 transmembrane 255 278 non-cytoplasmic 279 304 transmembrane 305 324 cytoplasmic 325 346 transmembrane 347 351 non-cytoplasmic 352 372 transmembrane 373 392 cytoplasmic 393 416 transmembrane 417 422 non-cytoplasmic 423 440 transmembrane 441 454 cytoplasmic
Input: >PfGW456L13_2756 LAQGFKPRHVTMLSIAGIIGAGLFVGSGHAIAAAGPAVLLAYLFSGLLVVLVMRMLGEMA VANPDTGSFSTYADQAIGRWAGFTIGWLYWWFWVLVIPIEALAAGHVLNQWFPQIDAWLF ALVSIIALVITNLFSVSKYGEFEFWFAMAKVVAIIGFIGVGFAVLMGWVPDREVSGLSGL MAEHGGFAPNGLSAVVGAFITIMFSFIGTEAVTIAAAESDNPSQNIAKATRSVIWRIGVF YLLSIFVVISVVPWNDPLLAQVGSYQRALEIMNIPHAKFMVDVVVLIAVASCMNSSIYIA SRMLYSLGRRGDAPKSLKATSSEGVPRAAVIASTVLGAAITVWSYFMPAGLFNFLLASSG AIALLVYLAIAVSQLRMRRMLRRQNIELTFRMWLFPWLTWLVIAFICAALAVMMITPEHR TEVSTTIGLALAISFIGLVTSRHPAQAARVTSVG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server